Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases

Clinical and Experimental Rheumatology

Volumn 15, Issue 2, 1997, Pages 201-210

  Perosa, F ^a   Scudeletti, M ^b   Imro, M A ^b   Dammacco, F ^a   Luccarelli, G ^a   Indiveri, F ^b,c  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

anti CD4 monoclonal antibodies; anti idiotypic monoclonal antibodies; immunotherapy

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; OKT 4;

AUTOIMMUNITY; DRUG EFFICACY; DRUG THERAPY; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0031010077     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. MARRACK P, KAPPLER JW: How the immune system recognizes the body. Scientific American 1993; 269: 80-3.
2. DOYLE C, STROMINGER JL: Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987; 330: 256-9.
3. GERMAIN RN, MARGUILES DH: The biochemistry and cell biology of antigen processing and presentation. Ann Rev Immunol 1993; 11:403.
4. ISHIOKA GY, ADORINI L, GUÉRY JC, GAETA FCA, LAFOND R, ALEXANDER J, POWELL MF, SETTE A, GREY HM: Failure to demonstrate long lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides. J Immunol 1994; 152: 4310-19.
5. REITHMÜLLER G, RIEBER EP, KIEFERSAUER S, PRINZ J, VAN DER LUBBE P, MEISER B, BREEDVELD F, EISENBURG J. KRÜGER K, DEUSCH K, SANDERS M, REITER C: From anti-lymphocyte serum to therapeutic monoclonal antibodies: First experiences with a chimeric CD4 antibody in the treatment of autoimmune disease. Immunol Rev 1992; 129: 81-104.
6. WILLIAMS RO, MASON LJ, FELDMANN M, MAINI RN: Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 1994; 91: 2762-6.
7. ADELMAN EN, WATLING LD, MCDEVITT HO: Treatment of (NZB × NZW) F1 disease with anti-I-A monoclonal antibodies. J Exp Med 1983; 158: 1350-5.
8. SEMPÉ P, BÉDOSSA P, RICHARD MF, VILLÀ M-C, BACH JF, BOITARD C: Anti α/β T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in non-obese diabetic (NOD) mice. Eur J Immunol 1991; 21: 1163-9.
9. DEBETS R, SALVELKOUL HJ: Cytokine antagonists and their potential therapeutic use. Immunol Today 1994; 15: 455-8.
10. lck. Cell 1988; 55: 301.
11. JAMALI I, FIELD EH, FLEMING A, COWDERY JS: Kinetics of anti-CD4-induced T helper cell depletion and inhibition of function. Activation of T cells by the CD3 pathway inhibits anti-CD4-mediated T cell elimination and down-regulation of cell surface CD4. J Immunol 1992; 148: 1613-19.
12. CARREL S, MORETTA A, TAMBUSSI G, ISLER P, PERUSSIA B, CEROTTINI J-C: Stimulation and proliferation of CD4+ peripheral blood T lymphocytes induced by an anti-CD4 monoclonal antibody. Eur J Immunol 1988; 18: 333-9.
13. HOWIE SEM, HARRINSON DJ, WYLLIE AH: Lymphocyte apoptosis-mechanisms and implications in diseases. Immunol Rev 1994: 142: 141-56.
14. NEWELL MK, HAUGHN LJ, MAROUN CR, JULINS MH: Death of mature T cells by separate ligation of CD4 and T cell receptor for antigen. Nature 1990; 347: 286-9.
15. BENJIAMIN RJ, WALDMAN H: Induction of tolerance by monoclonal antibody therapy. Nature 1986; 320: 449-51.
16. CARTERON NL, WOFSY D, SEAMANN WE: Induction of immune tolerance during the administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+. J Immunol 1988; 140: 713-16.
17. HERVÉ P, RACADOT E, WENDLING D, RUMBACH L, TIBERGHIEN P, CAHN JY, FLESCH M, WIJDENES J: Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: The Besançon experience. Immun Rev 1992; 129: 31-55.
18. VAN LAMBALGEN R, JONKER M: Experimental allergic encephalomyelitis in Rhesus monkeys. II. Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies. Clin Exp Immunol 1987; 68: 305-12.
19. RANGES GE, SRIRAM S, COOPERS SM: Prevention of type II collagen-induced arthritis by in vivo treatment with antiL3T4. J Exp Med 1985; 162: 1105-10.
20. JABS DA, BUREK CL, HU Q, KUPPERS RC, LEE B, PRENDERGAST RA: Anti-CD4 monoclonal antibody therapy suppresses autoimmune diseases in MRL/mp-lpr/lpr mice. Cell Immunol 1992; 141: 496-507.
21. SHIZURU JA, TAYLOR-EDWARDS C, BANKS BA, GREGORY AK, FATHMANN CG: Immunotherapy of non-obese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 1988; 240: 659-62.
22. CHOY EHS, CHIKANZA IC, KINGSLEY GH, CORRIGAL V, PANAYI GS: Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody. Stand J Immunol 1992; 36: 291-8.
23. ISAACS JD, WATTS RA, HAZLEMAN BL, HALE G, KEOGAN M T, COBBOLD SP, WALDMON H: Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet 1992; 340: 748-58.
24. HERZOG CH, WALKER CH, PICHLER W, AESCHLIMANN A, WASSMER P, STOCKINGER H, KNAPP W, RIEBER P, MÜLLER W: Monoclonal anti-CD4 in arthritis. Lancet 1987; 2: 1461-7.
25. HERZOG C, WALKER C, MÜLLER W, RIEBER P, REITER C, RIETHMÜLLER G, WASSMER P, STOCKINGER H, MADIC O, PICHLER WJK: Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmunity 1989; 2: 627-42.
26. WALKER C, HERZOG C, RIEBER P, RIETHMÜLLER G, MÜLLER W, PICLER WJ: Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells. J Autoimmunity 1989; 2: 643-9.
27. GOLDBERG D, MOREL P, CHATENOUD L, BOITARD C, MENKERS CJ, BERTOYE PH, REVILLARD JP, BACH JF: Immunological effect of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J Autoimmunity 1991; 4: 617-30.
28. REITER C, KAKAVAND B, RIEBER EB, SCHATTENKIRCHNER M, RIETHMÜLLER G, KRÜGER K: Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Arthritis Rheum 1991; 34: 525-36.
29. HORNEFF G, BURMESTER GR, EMMRICH F, KALDEN JR: Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 1991; 34: 129-40.
30. WENDLING D, WIJDENES J, RACADOT E, MORELFOURRIER B: Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. J Rheumatol 1991; 18: 325-7.
31. VAN DER LUBBE PA, REITER C, BREEDVELD FC, KRÜGER K, SCHATTENKIRCHNER M, SANDERS ME, RIETHMÜLLER G: Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. Arthritis Rheum 1993; 36: 1375-9.
32. MORELAND LW, BUCY RP, TILDEN A, PREATT PW, LOBUGLIO AF, KHAZAELI M, EVERSON MP, DADDONA P, GHRAYEB J, KILGARRIF C, SANDERS ME KOOPMAN W: Use of chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis. Arthritis Rheum 1993; 36: 307-18.
33. MORELAND LW, PRATT PW, BUCY RP, TILDEN PW, LOBUGLIO A, KHAZAELI M, EVERSON MP, DADDONA P, GHRAYEB J, KILGARRIFFC C, SANDERS ME, KOOPMAN WJ: Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Arhritis Rheum 1994; 37: 834-8.
34. HAFLER DA, RITZ J, SCHLOSSMAN SF, WEINER HL: Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. J Immunol 1988; 141: 131-8.
35. MATHIESON PW, COBBOLD SP, HALE G, CLARK MR, OLIVEIRA DBG, LOCTKWOOD CM, WALDMANN H: Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med 1990; 323: 250-4.
36. HIEPE F, VOLK H-D, APOSTOLOFF E, BAHER RV, EMMRICH F: Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody. Lancet 1991; 338: 1529-1530.
37. NICOLAS JF, CHAMCHICK N, THIVOLET J, WIJDENES J, MOREL P, REVILLARD JP: CD4 antibody treatment of severe psoriasis. Lancet 1991; 338: 321.
38. PRINZ J, BRAUN-FALCO O, MEURER M, DADDONA P, REITER C, REIBER P, RIETHMÜLLER G: Chimaeric CD4 monoclonal antibody in treatment of generalized pustular psoriasis. Lancet 1991; 338: 320-1.
39. VAN DER LUBBE PA, MILTENBERG AM, BREEDVELD FC: Anti-CD4 monoclonal antibody for relapsing polychondritis. Lancet 1991; 337: 1349.
40. EMMRICH J, SEYFARTH M, FLEIG WE, EMMRICH F: Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody. Lancet 1991; 338: 570-1.
41. KAKAVAND B, REITER C, RIEBER EP, REITHMÜLLER G, EISENBURG J: Therapeutische CD4-T zelldepletion mit hilfe chimärischer, monoklonaler CD4-antikörper zur therapie der autoimmunen, chronischen hepatitis. Klin Wochenschrift 1992; 69 (Suppl. XXVIII): 51 (Abstract).
42. MAUTHE B, ENDRES N, REITER C, REITHMÜLLER G, CLASSEN M, DEUSH K: Chimeric monoclonal anti-CD4 antibody therapy proves effective for treating inflammatory bowel disease. (Abstract) VIII Frühjahrstagung der Gesellschaft für Immunologie, Marz 1992 (Abstract).
43. KARSH J, KLIPPEL JH, PLOTZ PH, DECKER JL, WRITE DG, FLYE MW: Lymphapheresis in rheumatoid arthritis. Arthritis Rheum 1981; 24: 867-73.
44. TRENTHAM DE, BELLI JA, ANDERSON RJ, BUCKLEY JA, GOETZL EJ, DAVID JR, AUSTEN KF: Clinical and immunogical effects of fractionated total lymphoid irradiation in refractory rheumatoid arthitis. N Engl J Med 1981; 305: 976-82.
45. POULTER LW, DUKE O, PANAYI GS, HOBBS S, RAFTERY MJ, JANOSSY G: Activated T lymphocytes in the synovial membrane in rheumatoid arthritis and other arthropathies. Stand J Immunol 1985; 22: 683-90.
46. MAURER D, FELZMANN T, HOLTER W, PETERA P, SMOLEN J, KNAPP W: Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol 1992; 87: 429-34.
47. MORELAND L, PRATT P, MAYES M, POSTLETHWAITE A, WEISMAN M, SCHNITZER T, LIGHTFOOT R, CALABRESE L, KOOPMANN W: Minimal efficacy of a depleting chimeric anti-CD4 (cM-T412) in treatment of patients with refractory rheumatoid arthritis (RA) receiving concomitant methotrexate (MTX). Arthritis Rheum 1993; 36: S39 (Abstract).
48. JANEWAY CA: The co-receptor function of murine CD4. Semin Immunol 1991; 3: 153-60.
49. PEROSA F, DAMMACCO F: Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit. Int J Clin Lab Res 1994; 24: 208-12.
50. PEROSA F, DAMMACCO F: Human CD4 "internal antigen" mimicry by anti-idiotypic antibodies, lnt J Clin Lab Res 1994; 24: 33-40.
51. PEROSA F, FERRONE S, DAMMACCO F: Anti-idiotypic monoclonal antibody reacting with idiotope on isolated-denatured chains of an anti-CD4 monoclonal antibody. Immunology 1991; 74: 748-50.